172 related articles for article (PubMed ID: 26924047)
1. Targeted rescue of a polycystic kidney disease mutation by lysosomal inhibition.
Hofherr A; Wagner CJ; Watnick T; Köttgen M
Kidney Int; 2016 Apr; 89(4):949-55. PubMed ID: 26924047
[TBL] [Abstract][Full Text] [Related]
2. TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.
Magistroni R; Mangolini A; Guzzo S; Testa F; Rapanà MR; Mignani R; Russo G; di Virgilio F; Aguiari G
BMC Nephrol; 2019 Sep; 20(1):355. PubMed ID: 31514750
[TBL] [Abstract][Full Text] [Related]
3. Role of TRPP2 in mouse airway smooth muscle tension and respiration.
Sang D; Bai S; Yin S; Jiang S; Ye L; Hou W; Yao Y; Wang H; Shen Y; Shen B; Du J
Am J Physiol Lung Cell Mol Physiol; 2019 Oct; 317(4):L466-L474. PubMed ID: 31411061
[TBL] [Abstract][Full Text] [Related]
4. The Structure of the Polycystic Kidney Disease Channel PKD2 in Lipid Nanodiscs.
Shen PS; Yang X; DeCaen PG; Liu X; Bulkley D; Clapham DE; Cao E
Cell; 2016 Oct; 167(3):763-773.e11. PubMed ID: 27768895
[TBL] [Abstract][Full Text] [Related]
5. cDNA cloning of porcine PKD2 gene and RNA interference in LLC-PK1 cells.
Wang Q; Yin H; He J; Ye J; Ding F; Wang S; Hu X; Meng Q; Li N
Gene; 2011 May; 476(1-2):38-45. PubMed ID: 21277361
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
[TBL] [Abstract][Full Text] [Related]
7. Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a TRPP2 (polycystin-2)-dependent manner.
Waheed A; Ludtmann MH; Pakes N; Robery S; Kuspa A; Dinh C; Baines D; Williams RS; Carew MA
Br J Pharmacol; 2014 May; 171(10):2659-70. PubMed ID: 24116661
[TBL] [Abstract][Full Text] [Related]
8. The native TRPP2-dependent channel of murine renal primary cilia.
Kleene SJ; Kleene NK
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F96-F108. PubMed ID: 27760766
[TBL] [Abstract][Full Text] [Related]
9. Is it Time to Fold the Cysts Away?
Krappitz M; Gallagher AR; Fedeles S
Trends Mol Med; 2016 Dec; 22(12):997-999. PubMed ID: 27793600
[TBL] [Abstract][Full Text] [Related]
10. TRPP2 and autosomal dominant polycystic kidney disease.
Köttgen M
Biochim Biophys Acta; 2007 Aug; 1772(8):836-50. PubMed ID: 17292589
[TBL] [Abstract][Full Text] [Related]
11. Function and regulation of TRPP2 ion channel revealed by a gain-of-function mutant.
Arif Pavel M; Lv C; Ng C; Yang L; Kashyap P; Lam C; Valentino V; Fung HY; Campbell T; Møller SG; Zenisek D; Holtzman NG; Yu Y
Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2363-72. PubMed ID: 27071085
[TBL] [Abstract][Full Text] [Related]
12. Three exonic mutations in polycystic kidney disease-2 gene (PKD2) alter splicing of its pre-mRNA in a minigene system.
Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
Gene; 2016 Mar; 578(1):117-23. PubMed ID: 26692149
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Loops Are Essential for the Assembly and Function of Polycystin Receptor-Ion Channel Complexes.
Salehi-Najafabadi Z; Li B; Valentino V; Ng C; Martin H; Yu Y; Wang Z; Kashyap P; Yu Y
J Biol Chem; 2017 Mar; 292(10):4210-4221. PubMed ID: 28154010
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid residue constitutes the third dimerization domain essential for the assembly and function of the tetrameric polycystin-2 (TRPP2) channel.
Feng S; Rodat-Despoix L; Delmas P; Ong AC
J Biol Chem; 2011 May; 286(21):18994-9000. PubMed ID: 21474446
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation determines the abundance of the transient receptor potential channel TRPP2.
Hofherr A; Wagner C; Fedeles S; Somlo S; Köttgen M
J Biol Chem; 2014 May; 289(21):14854-67. PubMed ID: 24719335
[TBL] [Abstract][Full Text] [Related]
17. Submembraneous microtubule cytoskeleton: interaction of TRPP2 with the cell cytoskeleton.
Chen XZ; Li Q; Wu Y; Liang G; Lara CJ; Cantiello HF
FEBS J; 2008 Oct; 275(19):4675-83. PubMed ID: 18754774
[TBL] [Abstract][Full Text] [Related]
18. Function and regulation of TRPP2 at the plasma membrane.
Tsiokas L
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F1-9. PubMed ID: 19244406
[TBL] [Abstract][Full Text] [Related]
19. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
Hoefele J; Mayer K; Scholz M; Klein HG
Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
[TBL] [Abstract][Full Text] [Related]
20. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.
Mekahli D; Decuypere JP; Sammels E; Welkenhuyzen K; Schoeber J; Audrezet MP; Corvelyn A; Dechênes G; Ong AC; Wilmer MJ; van den Heuvel L; Bultynck G; Parys JB; Missiaen L; Levtchenko E; De Smedt H
Pflugers Arch; 2014 Aug; 466(8):1591-604. PubMed ID: 24193408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
